Nektar Therapeutics Inventory
Nektar Therapeutics (NKTR) had Inventory of $0 as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-03-13
- 2025-12-31: Inventory, Net $0.00.
- 2024-12-31: Inventory, Net $0.00.
- 2024-09-30: Inventory, Net $0.00.
- 2024-06-30: Inventory, Net $14.46M.
| Period end | Inventory, Net |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-13 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 |
| 2024-06-30 | $14.46M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $16.24M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $16.10M 10-K · filed 2025-03-14 |
| 2023-09-30 | $15.13M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $20.69M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $20.23M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $19.20M 10-K · filed 2024-03-05 |
| 2022-09-30 | $19.06M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $16.97M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $15.38M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $15.80M 10-K · filed 2023-02-28 |
| 2021-09-30 | $15.33M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $14.62M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $16.81M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $15.29M 10-K · filed 2022-03-01 |
| 2020-09-30 | $12.89M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $12.58M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $14.32M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $12.66M 10-K · filed 2021-02-26 |
| 2019-09-30 | $13.72M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $13.19M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $11.78M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $11.38M 10-K · filed 2020-02-28 |
| 2018-09-30 | $13.30M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $11.88M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $10.68M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $10.73M 10-K · filed 2019-03-01 |
| 2017-09-30 | $13.65M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $11.01M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $13.02M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $11.11M 10-K · filed 2018-03-01 |
| 2016-09-30 | $10.75M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $10.26M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $11.25M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $11.35M 10-K · filed 2017-03-01 |
| 2015-09-30 | $10.35M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $10.12M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $12.51M 10-Q · filed 2015-05-01 |
| 2014-12-31 | $12.95M 10-K · filed 2016-02-29 |
| 2014-09-30 | $11.70M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $14.11M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $12.87M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $13.45M 10-K · filed 2015-02-26 |
| 2013-09-30 | $15.08M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $20.48M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $18.38M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $18.27M 10-K · filed 2014-02-27 |
| 2012-09-30 | $16.75M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $14.71M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $14.11M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $12.66M 10-K · filed 2013-03-01 |
| 2011-09-30 | $10.65M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $9.80M 10-Q · filed 2011-08-05 |
| 2011-03-31 | $11.71M 10-Q · filed 2011-04-29 |
| 2010-12-31 | $7.27M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |